{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:17:12Z","timestamp":1793348232197,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejmech.2022.114358","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T03:02:17Z","timestamp":1649905337000},"page":"114358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease"],"prefix":"10.1016","volume":"237","author":[{"given":"Leonardo","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Leuci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Occhineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Baltrukevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Laghezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo Damiano","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Am\u00e9lia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Loiodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-5818","authenticated-orcid":false,"given":"Luca","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114358_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.ejmech.2022.114358_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ejmech.2022.114358_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of alzheimer's disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2022.114358_bib4","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.3390\/app10124118","article-title":"Importance of biometals as targets in medicinal chemistry: an overview about the role of zinc (II) chelating agents","volume":"10","author":"Leuci","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejmech.2022.114358_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/pr10010132","article-title":"Metal ions, metal chelators and metal chelating assay as antioxidant method","volume":"10","author":"Gulcin","year":"2022","journal-title":"Process"},{"key":"10.1016\/j.ejmech.2022.114358_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00204-020-02689-3","article-title":"Antioxidants and antioxidant methods: an updated overview","volume":"94","author":"Gulcin","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114358_bib7","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","article-title":"Metal ions in alzheimer's disease: a key role or not?","volume":"52","author":"Liu","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114358_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2022.114358_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer's disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2022.114358_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnagi.2015.00127","article-title":"Editorial: metals and neurodegeneration: restoring the balance","volume":"7","author":"White","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2022.114358_bib11","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.2174\/0929867328666210218183032","article-title":"Recent multi-target approaches on the development of anti-alzheimer\u2019s agents integrating metal chelation activity","volume":"28","author":"Chaves","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib12","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer's disease","volume":"11","author":"Van Der Velpen","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ejmech.2022.114358_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and alzheimer's disease: bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2022.114358_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in\u00a0vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114358_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108555","article-title":"The cannabinoid system and microglia in health and disease","volume":"190","author":"Duffy","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114358_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2022.114358_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147135","article-title":"Endocannabinoid system alterations in Alzheimer's disease: a systematic review of human studies","volume":"1749","author":"Berry","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.ejmech.2022.114358_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-141635","article-title":"The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease","volume":"43","author":"Bedse","year":"2015","journal-title":"J.\u00a0Alzheimer\u2019s Dis. JAD."},{"key":"10.1016\/j.ejmech.2022.114358_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's Chorea, alzheimer's disease, and others","volume":"231","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114358_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114358_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/1673-5374.264458","article-title":"Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's disease","volume":"15","author":"Brunetti","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2022.114358_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/1673-5374.241043","article-title":"An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions","volume":"14","author":"Piemontese","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2022.114358_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/molecules27030958","article-title":"A\u00a0new series of aryloxyacetic acids endowed with multi-target activity towards peroxisome proliferator-activated receptors (PPARs), fatty acid amide hydrolase (FAAH), and acetylcholinesterase (AChE)","volume":"27","author":"Leuci","year":"2022","journal-title":"Mol"},{"key":"10.1016\/j.ejmech.2022.114358_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2022.114358_bib25","article-title":"The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease","author":"Jain","year":"2021","journal-title":"Cell Biochem. Funct"},{"key":"10.1016\/j.ejmech.2022.114358_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040502","article-title":"Anti-inflammatory effects of fatty acid amide hydrolase inhibition in monocytes\/macrophages from alzheimer's disease patients","volume":"11","author":"Chiurchi\u00f9","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/14756366.2014.928704","article-title":"Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates","volume":"30","author":"G\u00f6cer","year":"2015","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib28","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.bmc.2015.04.019","article-title":"Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones","volume":"23","author":"Akincio\u0287lu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejmech.2022.114358_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","article-title":"Alzheimer's disease, the \u201cone-molecule, one-target\u201d paradigm, and the multitarget directed ligand approach","volume":"9","author":"Oset-Gasque","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114358_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib32","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170712161829","article-title":"An overview of new possible treatments of alzheimer's disease, based on natural products and semi-synthetic compounds","volume":"24","author":"Zanforlin","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom11010111","article-title":"Derivatives of tenuazonic acid as potential new multi-target anti-alzheimer\u2019s disease agents","volume":"11","author":"Poliseno","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib34","doi-asserted-by":"crossref","first-page":"104684","DOI":"10.1016\/j.bioorg.2021.104684","article-title":"Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: molecular dynamic, in\u00a0vitro and in\u00a0vivo studies","volume":"109","author":"Maleki","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib35","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/molecules26113254","article-title":"New Coumarin derivatives as cholinergic and cannabinoid system modulators","volume":"26","author":"Montanari","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197026","article-title":"Beyond the canonical endocannabinoid system. A screening of ppar ligands as FAAH inhibitors","volume":"21","author":"Brunetti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114358_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040985","article-title":"Design, synthesis, and in\u00a0vitro evaluation of hydroxybenzimidazole-donepezil analogues as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"25","author":"Chaves","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib38","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/14756366.2018.1491564","article-title":"Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer\u2019s drug candidates","volume":"33","author":"Piemontese","year":"2018","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib39","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/molecules26061658","article-title":"Novel donepezil\u2013arylsulfonamide hybrids as multitarget-directed ligands for potential treatment of alzheimer's disease","volume":"26","author":"Queda","year":"2021","journal-title":"Mol"},{"key":"10.1016\/j.ejmech.2022.114358_bib40","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4103\/1673-5374.213541","article-title":"Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy","volume":"12","author":"Hiremathad","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2022.114358_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030574","article-title":"Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil-Like Compounds","volume":"25","author":"Piemontese","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm201306q","article-title":"Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity","volume":"55","author":"Porcelli","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092182","article-title":"Natural scaffolds with multi-target activity for the potential treatment of Alzheimer's disease","volume":"23","author":"Piemontese","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114358_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/14756366.2019.1689237","article-title":"Novel tacrine\u2013benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease","volume":"35","author":"Fancellu","year":"2020","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib45","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/acs.jcim.9b01073","article-title":"Donepezil inhibits acetylcholinesterase via multiple binding modes at room temperature","volume":"60","author":"Silva","year":"2020","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114358_bib46","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1073\/pnas.94.6.2238","article-title":"Molecular characterization of human and mouse fatty acid amide hydrolases","volume":"94","author":"Giang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114358_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2022.114358_bib48","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1073\/pnas.0806121105","article-title":"Structure-guided inhibitor design for human FAAH by interspecies active site conversion","volume":"105","author":"Mileni","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114358_bib49","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A\u00a0BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114358_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejmech.2022.114358_bib51","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2022.114358_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0003-2670(01)80616-4","article-title":"A\u00a0study of some problems in determining the stoicheiometric proton dissociation constants of complexes by potentiometric titrations using a glass electrode","volume":"38","author":"Irving","year":"1967","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.ejmech.2022.114358_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/DT9930000927","article-title":"A\u00a0new iron(III) ion sequestering ligand: synthesis, solution chemistry and electrochemistry","author":"Santos","year":"1993","journal-title":"J.\u00a0Chem. Soc. Dalt. Trans."},{"key":"10.1016\/j.ejmech.2022.114358_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0020-1693(00)87525-8","article-title":"Siderophore analogues. Chelating properties of a new cyclic diazadihydroxamic acid","volume":"214","author":"Santos","year":"1993","journal-title":"Inorganica Chim. Acta."},{"key":"10.1016\/j.ejmech.2022.114358_bib55","series-title":"The Constitution of Complex Metallic Salts. Part XVIII. The Chelated Metallic Derivatives of NNN'N\u2032-tetramethylethylene-diamine and of 1:4-dimethylpiperazine","first-page":"2772","author":"Mann","year":"1958"},{"key":"10.1016\/j.ejmech.2022.114358_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0277-5387(00)00604-5","article-title":"Piperazine (and derivatives) copper(II) compounds: 1,4-dimethylpiperazin-1,4-ium tetrachlorocuprate(II) and Cu-N bond formation in trichloro(1-methylpiperazin-1-ium-N4)copper(II) and trichloro(1,4-dimethylpiperazin-1-ium-N4)copper(II)","volume":"20","author":"Marzotto","year":"2001","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2022.114358_bib57","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1021\/ic00299a014","article-title":"Exogenous bridging and nonbridging in copper(II) complexes of a binucleating 2,6-bis((N-methylpiperazino)methyl)-4-chlorophenolate ligand. Crystal structures and magnetic properties of bis(\u03bc-acetato), Dinitrito, and bis(azido) complexes","volume":"27","author":"Bertoncello","year":"1988","journal-title":"Possible Relevanc, Inorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0020-1693(00)80196-6","article-title":"Transition metal complexes of two related pyrazole containing ligands:3,6-dimethyl-1,8-(3,5-dimethyl-1-pyrazolyl)-3,6-diazaoctane (ddad) and 1,4-bis(2-ethyl-(3,5-dimethyl-1-pyrazolyl))-piperazine (bedp). Synthesis, spectroscopy and X-ray structures","volume":"189","author":"Haanstra","year":"1991","journal-title":"Inorganica Chim. Acta."},{"key":"10.1016\/j.ejmech.2022.114358_bib59","doi-asserted-by":"crossref","first-page":"16503","DOI":"10.1039\/C8NJ00117K","article-title":"Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer\u2019s agents","volume":"42","author":"Chaves","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111039","article-title":"Donepezil-based hybrids as multifunctional anti-Alzheimer\u2019s disease chelating agents: effect of positional isomerization","volume":"206","author":"Costa","year":"2020","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2022.114358_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A\u00a0perspective on multi-target drugs for alzheimer's disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114358_bib62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114358_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2017.08.004","article-title":"Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: a water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity","volume":"109","author":"Pisani","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2022.114358_bib64","series-title":"Schr\u00f6dinger Release 2021-1","author":"Schr\u00f6dinger","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114358_bib65","unstructured":"QUACPAC 2.1.0.4, OpenEye Scientific Software, Santa Fe, NM, http:\/\/www.eyesopen.com, (n.d.). www.eyesopen.com."},{"key":"10.1016\/j.ejmech.2022.114358_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J.\u00a0Cheminform."},{"key":"10.1016\/j.ejmech.2022.114358_bib67","doi-asserted-by":"crossref","first-page":"108698","DOI":"10.1016\/j.cbi.2019.06.011","article-title":"A\u00a0new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlits","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2022.114358_bib68","doi-asserted-by":"crossref","first-page":"113397","DOI":"10.1016\/j.ejmech.2021.113397","article-title":"Discovery of multifunctional anti-Alzheimer\u2019s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and \u03b3-aminobutyric acid transporters","volume":"218","author":"Pasieka","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/ja308733u","article-title":"A\u00a0binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase","volume":"135","author":"Bertolacci","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114358_bib70","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/ja00124a002","article-title":"A\u00a0second generation force field for the simulation of proteins, nucleic acids, and organic molecules","volume":"117","author":"Bayly","year":"1995","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114358_bib71","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib72","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10822-019-00240-w","article-title":"Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R Grand Challenge 4","volume":"33","author":"El Khoury","year":"2019","journal-title":"J.\u00a0Comput. Aided. Mol. Des."},{"key":"10.1016\/j.ejmech.2022.114358_bib73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/jm2005145","article-title":"A\u00a0force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking","volume":"55","author":"Forli","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114358_bib74","unstructured":"OpenEye Scientific Software, ROCS, 3.4.0.4, OpenEye Scientific Software, Santa Fe, NM, hhtp:\/\/www.eyesopen.com, (n.d.). hhtp:\/\/www.eyesopen.com."},{"key":"10.1016\/j.ejmech.2022.114358_bib75","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/ed042p375","article-title":"Potentiometric titrations using gran plots: a textbook omission","volume":"42","author":"Rossotti","year":"1965","journal-title":"J.\u00a0Chem. Educ."},{"key":"10.1016\/j.ejmech.2022.114358_bib76","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1039\/C2DT32361C","article-title":"A\u00a0novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in\u00a0vivo studies","volume":"42","author":"Chaves","year":"2013","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.ejmech.2022.114358_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jinorgbio.2003.10.001","article-title":"A\u00a0formula for correlating pKa values determined in D2O and H2O","volume":"98","author":"Kr\u0229zel","year":"2004","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2022.114358_bib78","series-title":"QikProp 2.5","year":"2005"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:40:44Z","timestamp":1759329644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":78,"alternative-id":["S0223523422002604"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114358","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114358"}}